In vitro biphasic dissolution tests and their suitability for establishing in vitro-in vivo correlations: A historical review

Pestieau, Aude; Evrard, Brigitte

doi:10.1016/j.ejps.2017.03.019

Article (Scientific journals)

In vitro biphasic dissolution tests and their suitability for establishing in vitro-in vivo correlations: A historical review

Pestieau, Aude; Evrard, Brigitte

2017 • In European Journal of Pharmaceutical Sciences, 102, p. 203-219

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/208448

DOI
10.1016/j.ejps.2017.03.019

PubMed
28315463

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Review biphasique pdf final.pdf

Publisher postprint (1.42 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] For many decades, one of the most critical issues in the pharmaceutical industry has been the poor solubility of some drugs. Indeed, a prerequisite for drug absorption is the presence of dissolved drug at the absorption site and this can be challenging for compounds with low aqueous solubility such as BCS class II (low solubility, high permeability) and IV (low solubility, low permeability) compounds. If the development of oral delivery formulations of these compounds is frequently challenging to formulation scientists in the pharmaceutical industry, the in vitro evaluation of these new formulations is also a great challenge. One alternative approach to overcome the problems encountered with conventional dissolution methods is the use of biphasic dissolution systems. This review provides an overview of the origin and the evolution over time of the biphasic systems and the growing interest among scientists regarding their suitability for establishing in vitro-in vivo correlations. The evolution of these systems and their applications from the 1960s to the present day, such as in system variants and improvements, analysis of complex formulations, discriminatory power, bio-relevance, precipitation and supersaturation visualization, etc. will be discussed.

Research center :

CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège

Disciplines :

Pharmacy, pharmacology & toxicology

Author, co-author :

Pestieau, Aude ; Université de Liège > Département de pharmacie > Pharmacie galénique

Evrard, Brigitte ; Université de Liège > Département de pharmacie > Pharmacie galénique

Language :

English

Title :

In vitro biphasic dissolution tests and their suitability for establishing in vitro-in vivo correlations: A historical review

Publication date :

01 May 2017

Journal title :

European Journal of Pharmaceutical Sciences

ISSN :

0928-0987

eISSN :

1879-0720

Publisher :

Elsevier Science, Amsterdam, Netherlands

Volume :

102

Pages :

203-219

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 21 March 2017

Statistics

Number of views

96 (8 by ULiège)

Number of downloads

3 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Al Durdunji, A., AlKhatib, H.S., Al-Ghazawi, M., Development of a biphasic dissolution test for Deferasirox dispersible tablets and its application in establishing an in vitro–in vivo correlation. Eur. J. Pharm. Biopharm. 102 (2016), 9–18.
Amidon, G., Lennernäs, H., Shah, V., Crison, J., A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995), 413–420.
Chaudhary, R., Gangwal, S., Gupta, V., Shah, Y., Jindal, K., Khanna, S., Dissolution system for nifedipine sustained release formulations. Drug Dev. Ind. Pharm. 19 (1993), 1939–1946.
Doluisio, J.T., Swintosky, J.V., Drug partitioning II in vitro model for drug absorption. J. Pharm. Sci. 53 (1964), 597–601.
Fini, A., Orienti, I., Tartarini, A., Rodrigues, L., Zecchi, V., Three phase dissolution-partition of some non-steroidal anti-inflammatory drugs. Acta Pharm. Technol. 32 (1986), 86–88.
Frank, K.J., Locher, K., Zecevic, D.E., Fleth, J., Wagner, K.G., In vivo predictive mini-scale dissolution for weak bases: advantages of pH-shift in combination with an absorptive compartment. Eur. J. Pharm. Sci. 61 (2014), 32–39.
Gabriëls, M., Plaizier-Vercammen, J., Design of a dissolution system for the evaluation of the release rate characteristics of artemether and dihydroartemisinin from tablets. Int. J. Pharm. 274 (2004), 245–260.
Gibaldi, M., Feldman, S., Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. J. Pharm. Sci. 56 (1967), 1238–1242.
Grassi, M., Coceani, N., Magarotto, L., Modelling partitioning of sparingly soluble drugs in a two-phase liquid system. Int. J. Pharm. 239 (2002), 157–169.
Grundy, J.S., Anderson, K.E., Rogers, J.A., Foster, R.T., Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro dissolution test. J. Control. Release 48 (1997), 1–8.
Grundy, J.S., Anderson, K.E., Rogers, J.A., Foster, R.T., Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. II. Improved in vitro-in vivo correlation using a two-phase dissolution test. J. Control. Release 48 (1997), 9–17.
Heigoldt, U., Sommer, F., Daniels, R., Wagner, K.-G., Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test. Eur. J. Pharm. Biopharm. 76 (2010), 105–111.
Kinget, R., De Greef, H., In vitro assessment of drug release from semi-solid lipid matrices. Eur. J. Pharm. Sci. 3 (1995), 105–111.
Levy, G., Leonards, J.R., Procknal, J.A., Development of in vitro dissolution tests which correlate quantitatively with dissolution rate-limited drug absorption in man. J. Pharm. Sci. 54 (1965), 1719–1722.
Locher, K., Borghardt, J.M., Frank, K.J., Kloft, C., Wagner, K.G., Evolution of a mini-scale biphasic dissolution model: impact of model parameters on partitioning of dissolved API and modelling of in vivo-relevant kinetics. Eur. J. Pharm. Biopharm. 105 (2016), 166–175.
Lu, E., Li, S., Wang, Z., Biorelevant test for supersaturable formulation. Asian J. Pharm. Sci. 12 (2017), 9–20.
Machida, Y., Tokumura, T., Komuro, S., Tsushima, Y., Tatsuishi, K., Kayano, M., Nagai, T., A new method of dissolution testing for oily drug preparations using an improved apparatus. Chem. Pharm. Bull. 34 (1986), 2637–2641.
Moya, E.S., Schulz, C.P., The aggregation of the sodium dodecyl sulfate–n - octanol–water system at low concentration. Colloid Polym. Sci. 277 (1999), 735–742.
Mudie, D.M., Amidon, G.L., Amidon, G.E., Physiological parameters for oral delivery and in vitro testing. Mol. Pharm. 7 (2010), 1388–1405.
Mudie, D.M., Shi, Y., Ping, H., Gao, P., Amidon, G.L., Amidon, G.E., Mechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatus. Biopharm. Drug Dispos. 33 (2012), 378–402.
Ngo, T.H., Quintens, I., Roets, E., Declerck, P., Hoogmartens, J., Bioavailability of different artemisinin tablet formulations in rabbit plasma—correlation with results obtained by an in vitro dissolution method. J. Pharm. Biomed. Anal. 16 (1997), 185–189.
Ngo, T.H., Vertommen, J., Kinget, R., Formulation of artemisinin tablets. Int. J. Pharm. 146 (1997), 271–274.
Niebergall, P.J., Patil, M.Y., Sugita, E.T., Simultaneous determination of dissolution and partitioning rates in vitro. J. Pharm. Sci. 56 (1967), 943–947.
Niebergall, P.J., Sugita, E.T., Schnaare, R.L., Dissolution rates under sink conditions. J. Pharm. Sci. 60 (1971), 1575–1576.
Pang, K.S., Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes. Drug Metab. Dispos. 31 (2003), 1507–1519.
Pestieau, A., Krier, F., Lebrun, P., Brouwers, A., Streel, B., Evrard, B., Optimization of a PGSS (particles from gas saturated solutions) process for a fenofibrate lipid-based solid dispersion formulation. Int. J. Pharm. 485 (2015), 295–305.
Pestieau, A., Krier, F., Brouwers, A., Streel, B., Evrard, B., Selection of a discriminant and biorelevant in vitro dissolution test for the development of fenofibrate self-emulsifying lipid-based formulations. Eur. J. Pharm. Sci. 92 (2016), 212–219.
Pestieau, A., Lebrun, S., Cahay, B., Brouwers, A., Streel, B., Cardot, J.-M., Evrard, B., Evaluation of different in vitro dissolution tests based on level A in vitro–in vivo correlations for fenofibrate self-emulsifying lipid-based formulations. Eur. J. Pharm. Biopharm. 112 (2017), 18–29.
Phillips, D.J., Pygall, S.R., Cooper, Brett, Mann, J.C., Toward biorelevant dissolution: application of a biphasic dissolution model as a discriminating tool for HPMC matrices containing a model BCS class II drug. Dissolut. Technol. 19 (2012), 25–34.
Pillay, V., Fassihi, R., Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J. Control. Release 55 (1998), 45–55.
Pillay, V., Fassihi, R., A new method for dissolution studies of lipid-filled capsules employing Nifedipine as a model drug. Pharm. Res. 16 (1999), 333–337.
Porges, E., Schade, B., Ropte, W., An automated flow-through method to determine the dissolution rate of slightly soluble substances. Pharm. Ind. 47 (1985), 77–86.
Shi, Y., Gao, P., Gong, Y., Ping, H., Application of a biphasic test for characterization of in vitro drug release of immediate release formulations of celecoxib and its relevance to in vivo absorption. Mol. Pharm. 7 (2010), 1458–1465.
Shi, Y., Erickson, B., Jayasankar, A., Lu, L., Marsh, K., Menon, R., Gao, P., Assessing supersaturation and its impact on in vivo bioavailability of a low-solubility compound ABT-072 with a dual pH, two-phase dissolution method. J. Pharm. Sci. 105 (2016), 2886–2895.
Stead, J.A., Freeman, M., John, E.G., Ward, G.T., Whiting, B., Ibuprofen tablets: dissolution and bioavailability studies. Int. J. Pharm. 14 (1983), 59–72.
Takahashi, M., Mochizuki, M., Itoh, T., Ohta, M., Studies on dissolution tests for soft gelatin capsules. IV. Dissolution test of nifedipine soft gelatin capsule containing water soluble vehicles by the rotating dialysis cell method. Chem. Pharm. Bull. 42 (1994), 333–336.
Takahashi, M., Yuasa, H., Kanaya, Y., Uchiyama, M., Studies on dissolution tests for soft gelatin capsules by the rotating dialysis cell (RDC) method. VI. Preparation and evaluation of ibuprofen soft gelatin capsule. Chem. Pharm. Bull. 43 (1995), 1398–1401.
Thiry, J., Broze, G., Pestieau, A., Tatton, A.S., Baumans, F., Damblon, C., Krier, F., Evrard, B., Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions. Eur. J. Pharm. Sci. 85 (2016), 94–105.
Thomas, N., Richter, K., Pedersen, T., Holm, R., Müllertz, A., Rades, T., In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate. AAPS J. 16 (2014), 539–549.
Thu Hoa, N., Kinget, R., Design and evaluation of two-phase partition–dissolution method and its use in evaluating artemisinin tablets. J. Pharm. Sci. 85 (1996), 1060–1063.
Vangani, S., Li, X., Zhou, P., Del-Barrio, M.-A., Chiu, R., Cauchon, N., Gao, P., Medina, C., Jasti, B., Dissolution of poorly water-soluble drugs in biphasic media using USP 4 and fiber optic system. Clin. Res. Regul. Aff. 26 (2009), 8–19.
Wurster, D.E., Polli, G.P., Investigation of drug release from solids IV. Influence of adsorption on the dissolution rate. J. Pharm. Sci. 50 (1961), 403–406.